Lung cancer patients could be given choice over treatment
Having radiotherapy once a day for 6.5 weeks, or twice a day for 3 weeks – when combined with chemotherapy – is equally good at treating small cell lung cancer that has not spread, a study suggests.
Patients with small cell lung cancer may benefit from daily radiotherapy. Photo: Science Photo Library
International researchers studied about 550 patients from across the world in the CONVERT trial – the largest ever trial completed in this group of patients.
Participants were split into 2 groups: the first group received radiotherapy twice a day over 3 weeks, and the second received radiotherapy once a day at a higher dose over 6.5 weeks. All patients also had chemotherapy.
Survival in both groups was similar: 56% who had radiotherapy twice a day survived for 2 years, compared with 51% of patients given radiotherapy once a day.
Want to read more?
Unlock full access to RCNi Plus today
Save over 50% on your first three months:
- Customisable clinical dashboard featuring 200+ topics
- Unlimited online access to all 10 RCNi Journals including Nursing Standard
- RCNi Learning featuring 180+ RCN accredited learning modules
- NMC-compliant RCNi Portfolio to build evidence for revalidation
- Personalised newsletters tailored to your interests